Searchable abstracts of presentations at key conferences in endocrinology

ea0044ep61 | (1) | SFEBES2016

A rare case of Follicular Stimulating Hormone (FSH) secreting pituitary adenoma in male

Kempegowda Punith , Ayuk John , Toogood Andrew

A 61-year-old man presented to his primary care service with complains of frequent hot flushes, dizziness and headache. Following initial screening, an incidental pituitary lesion was diagnosed on computed tomography (CT) scan and hence was referred to specialist review. Further detailed history revealed similar presentation with dizziness and hot flushes two and a half years ago. He was then diagnosed with essential hypertension after a negative work-up for Cushing disease. H...

ea0041gp205 | Thyroid - Translational & Clinical | ECE2016

One in four patients with adequately treated primary hypothyroidism continue to be symptomatic and persisting symptoms related to ongoing thyroid auto-immunity

Jacob Jubbin , Sebastain Ivy , John Mary

Background: A significant percentage of patients with adequately replaced primary hypothyroidism (PH) continue to be symptomatic. Some of these persisting symptoms maybe attributed to non-restoration of neurocognitive functions and psychological well-being.Objectives: To estimate the prevalence of persisting hypothyroid symptoms in patients with PH on biochemically adequate replacement therapy. To correlate persistent symptoms with thyroid hormone levels...

ea0059p091 | Diabetes & cardiovascular | SFEBES2018

Glycaemic control in group 2 license holders with diabetes mellitus

Drummond Samantha , Chalmers John , Gupta Saket

Background: Diabetes is a metabolic disorder characterized by chronic hyperglycaemia as a result of defective insulin secretion, insulin action or a combination. Poor glycaemic control increases the risk of microvascular and macrovascular complications. For group two driving license holders with diabetes there are specific requirements set out by the Driver and Vehicle Licensing Agency. It is therefore hypothesised that this patient group is likely to aim for less tight glycae...

ea0059ep46 | Clinical practice, governance & case reports | SFEBES2018

More than meets the eye - an unusual presentation of Cushing’s syndrome with bilateral central retinal vein occlusion

Kalaria Tejaskumar , Ayuk John , Buch Harit

A 53-year old male presented to his optician with blurring of vision on the right and was diagnosed to have branch retinal vein occlusion. Over the next 6 weeks he manifested further visual impairment, initially due to right central retinal venous occlusion (CRVO) and after another 3 months left CRVO. He received intravitreal Ranibizumab injections and timolol-dorzolamide eye drops in both eyes. Soon after this, he had a hospital admission for infected submandibular gland and ...

ea0038p10 | Bone | SFEBES2015

A mutation in the calcium sensing receptor (previously known to cause neonatal severe hyperparathyroidism in the homozygote state) causing familial benign hypocalciuric hypercalcaemia in the heterozygote

Hinnie John , Gallagher Andrew , Collie Angela

Familial Benign Hypocalciuric Hypercalcaemia (FBHH) is a benign autosomal dominant condition characterised by elevated serum calcium and parathyroid hormone (PTH) and low urine calcium. It is a genetically heterogeneous disorder but the majority of cases (type 1 FBHH) can be shown to be due inactivating mutations in the Calcium Sensing Receptor (CASR). This is a guanine nucleotide-binding-protein (G-protein) coupled receptor that signals through the G-protein subunit α11 ...

ea0058dp1.1 | Diabetes Professionals Day: Session 1 | BSPED2018

Empowering type 1 diabetes patients to self-manage by embracing the digital landscape of Diasend

Pemberton John , Krone Ruth , Dias Renuka

Successful management of diabetes requires an empowered patient/family that is well-educated about their condition and feels confident to self-manage with the support of their medical team. The linchpin to assessment and effective change is the quality of available information. Most patients/families have no way of pulling all their diabetes information together efficiently, and consequently often feel helpless and do not take charge of making their therapy adjustments. Diasen...

ea0058p003 | Adrenal | BSPED2018

Differences in hydrocortisone absorption during the 24 hour period in patients with adrenal insufficiency

Hindmarsh Peter , Charmandari Lia , Honour John

Hydrocortisone therapy should be individualised in patients with adrenal insufficiency to avoid over and under replacement. We assessed hydrocortisone absorbtion at different times of day which may impact on treatment regimens. We assessed the oral absorption of hydrocortisone in 48 patients (21M) aged between 6.1 and 20.3 years with congenital adrenal hyperplasia due to P450c21 deficiency. Hydrocortisone dosing ranged between 11.5 and 22.6 mg/m2 per day in three or...

ea0058p062 | Diabetes | BSPED2018

KISS Advanced Bolus System for managing the post-prandial glycemic effect of fat and protein in young people with T1D

Pemberton John , Leal Catarina , Hilary McCoubrey

Objectives: The Diabetes Team at Birmingham Children’s Hospital modified the advanced bolus algorithm suggested by Bell (2015), to develop the KISS (Keep it Simple and Safe). KISS involves adding 25% extra insulin to meals identified as very high fat and protein, and spreading the insulin by a split bolus, 50% now and 50% over 2.5 hours. KISS also has an adjustment tool allowing extra insulin to be added and the split modified from monitoring. KISS is intended to be a sim...

ea0034p65 | Clinical practice/governance and case reports | SFEBES2014

Spontaneous hypoglycaemia in a non-diabetic patient with insulin antibodies

Graham Una , McQuillan Laura , Lindsay John

A 58-year-old non-diabetic Caucasian man was admitted with a capillary glucose of 1.9 mmol/l following an episode of confusion and disorientation. During his admission he had frequent episodes of nocturnal and early morning hypoglycaemia with capillary glucose <3.0 mmol/l. After 21 h of supervised fasting he was symptomatic with plasma glucose 2.3 mmol/l, insulin >1000 mU/l and C-peptide 19.6 μg/l. Sulphonylurea screen was negative. Given the magnitude of serum in...

ea0034p380 | Thyroid | SFEBES2014

Suspected DVT after thyrotoxicosis

Kakad Rakhi , Haque Munirul , Milles John

We present the case of a young man who had been known to the endocrine department with difficult to control hyperthyroidism and atrial fibrillation. After a period of treatment with carbimazole, during which he missed several appointments, he was referred for radioactive iodine therapy, which was administered in January 2013. He failed to attend for follow-up appointments and continued to take carbimazole.He was subsequently referred to the acute medicin...